National Advocates for Pregnant Women and If/When/How Letter to FDA Opposing Restrictions on Abortion Medication

National Advocates for Pregnant Women and If/When/How wrote and organized a letter sent to the FDA, signed by organizations and experts in reproductive health and rights, public health, harm reduction, and HIV/AIDS. The letter opposes the recent warning letters targeting mifepristone and misoprostol as dangerous, and urges the FDA to remove the REMS for mife. The signatories urge the FDA to revoke the warning letters issued to websites allegedly distributing these medications to consumers in light of the worsening landscape for access to safe abortion in the U.S., and remove the unnecessary and onerous REMS that prevent people from accessing safe and effective medications.

Click here to read the letter.

Archives

Atom Feed